The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 254.00
Bid: 255.00
Ask: 256.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.392%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 254.00
CMCX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Oct 2022 07:00

RNS Number : 9379B
CMC Markets Plc
06 October 2022
 

6 October 2022

CMC Markets Plc

 

H1 2023 Pre-Close Trading Update

For the six months ended 30 September 2022

 

Net operating income c 20% higher versus H1 2022. Strategic delivery of 3-year growth plan on track. CMC Invest launched in the UK.

CMC Markets Plc ("CMC" or the "Group"), a leading global provider of online ("D2C") trading and institutional ("B2B") platform technology, today issues a trading update for the six months to 30 September 2022 ("H1 2023" or "the period").

Financial Highlights

H1 2023 net operating income is expected to be approximately £153 million. (H1 2022: £127 million +21% yoy).H1 2023 leveraged gross client income is expected to be approximately £155 million (H1 2022: £127 million +22% yoy).H1 2023 leveraged net trading revenue is expected to be approximately £128 million (H1 2022: £101 million +27% yoy).H1 2023 non-leveraged net trading revenue is expected to be approximately £21 million (H1 2022: £24 million -14% yoy).

 

Operational Highlights

The CMC Group is proud to launch its new UK investment platform - CMC Invest - with the aim of supporting customers throughout their entire investment journey. Further functionality will be added in coming months to enhance customer experience.Planned new business expansion to grow group net operating income by 30% over the next three years based on the 2022 results and underlying conditions remains on track.

 

Trading Update

Underlying market activity improvement through August and September underpinned an improvement in net operating income for the Group in the period.

Client leveraged AUM finished at c £530 million, slightly below the historical period-end record of c £560 million but remaining at elevated levels. H1 2023 active leveraged clients are moderately lower compared to H1 2022, offset by an overall increase in activity.

In H1 our Australian stockbroking business finished the period with a modest reduction in AUA from historical record levels which is in line with Australian market performance. Activity remains elevated versus pre-pandemic levels. The migration of over 500,0000 clients as of part the ANZ Share Investing acquisition deal is on track and scheduled to finish in H2 this financial year.

With over three decades of financial markets experience and trusted heritage the CMC Group launched its new UK investment platform, CMC Invest on 30 September 2022. CMC Invest is an investment platform, driven by the needs of customers, aiming to help them build their own personal investment strategy. Further product functionality will be added in coming months to enhance our customer's experience. It forms part of the steady diversification strategy for the Group.

CMC's business expansion plans to grow net operating income by 30% over next three years through the addition of additional products, and geographical expansion based on the 2022 result and underlying conditions remains on track. Further details will be provided in CMC's H1 results on 16 November 2022. 

Operating costs for H1 2023, excluding variable remuneration, are expected to be approximately £109 million (H1 2022: £84 million). Operating cost guidance for FY 2023 remains unchanged at £215 million excluding variable remuneration. Further sustained GBP weakness to put pressure on non-GBP denominated costs, although this is expected to have a net positive effect on profit due to non-GBP denominated revenue.

The results for the six months ended 30 September 2022 will be announced on 16 November 2022.

 

Lord Cruddas, Chief Executive Officer, commented:

"We closed the first six months with a pickup in market volatility and client trading volumes driving an improvement in operating income versus last year. As part of our diversification strategy, we are pleased to have launched our new UK non-leveraged business, CMC Invest. This move into self-directed investing marks a significant milestone for us, representing a major opportunity for growth and diversification into the non-leveraged market. While it is still in its initial stages of development, as we plan to add further functionality over the coming months, our goal is to provide unrivalled market access to investors through the best technology and lower transactional costs and fees. We believe commissions, execution spreads and custodial fees have for too long been too high and too expensive for retail investors. CMC Invest will leverage our platform technology, including pricing and execution enhancements to drive down the transaction costs of investments for retail clients, just like we did in Australia, where we are already the number two investment platform for retail investors.

We are on a fast track to diversification, using our existing platform technology to win B2B and B2C non-leveraged business. Our strategic growth plans are on track and set to deliver significant new business expansion as we introduce new products across our retail, institutional and stockbroking businesses. We look forward to updating you more in our H1 results on 16 November 2022."

 

Enquiries

CMC Markets Plc

James Cartwright, Investor Relations investor.relations@cmcmarkets.com

Euan Marshall, Chief Financial Officer

 

Camarco +44 (0) 20 3757 4994

Geoffrey Pelham-Lane

Jennifer Renwick

 

Notes to Editors

 

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Group serves retail and institutional clients through regulated offices and branches in 12 countries, with a significant presence in the UK, Australia, Germany, and Singapore. CMC offers an award-winning, online, and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities, and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKESEENAFFA
Date   Source Headline
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM
27th Jul 20237:00 amRNSTrading Statement
21st Jul 202311:20 amRNSDirector/PDMR Shareholding
21st Jul 202310:07 amRNSDirector/PDMR Shareholding
12th Jul 202310:27 amRNSDirector/PDMR Shareholding
7th Jul 202310:09 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSDirectorate Change
23rd Jun 20235:09 pmRNSNotice of AGM
13th Jun 20237:00 amRNSFinal Results
9th Jun 20237:00 amRNSInvestment in StrikeX Technologies
6th Jun 20231:48 pmRNSDirector/PDMR Shareholding
9th May 20231:34 pmRNSDirector/PDMR Shareholding
6th Apr 20233:40 pmRNSDirector/PDMR Shareholding
31st Mar 202310:56 amRNSHolding(s) in Company
27th Mar 20233:51 pmRNSTrading Statement
7th Mar 20232:49 pmRNSDirector/PDMR Shareholding
7th Feb 202311:37 amRNSDirector/PDMR Shareholding
25th Jan 20237:00 amRNSTrading Statement
9th Jan 20232:15 pmRNSDirector/PDMR Shareholding
9th Jan 202312:50 pmRNSDirector/PDMR Shareholding
6th Jan 20233:22 pmRNSDirector/PDMR Shareholding
14th Dec 202212:38 pmRNSDirectorate Change
6th Dec 20222:38 pmRNSDirector/PDMR Shareholding
21st Nov 20221:54 pmEQSCMC Markets 'to continue rolling out investment platform'

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.